The Epstein-Barr Virus Early Antigen D Antibody (IgG) test contains 1 test with 1 biomarker.
Primary infection by EBV causes infectious mononucleosis, usually a self-limiting disease in children and young adults. Infection with EBV can cause lymphoproliferative disorders including tumors. IgG recognizing Early Antigen D typically appears within a month after clinical presentation and is transient, lasting only 3-4 months. Persistently elevated levels suggest reactivation or persistence of EBV infection.
The Epstein-Barr EBV Early Antigen D Ab IgG test that will let one know if the virus is actively replicating.